A report says , which has operations in Durham as well as Beijing, has announced its commitment to support a combination therapy called BRII-196/BRII-198.
鈥淪o far, this therapy and other monoclonal antibodies show effectiveness against the Delta variant, which now accounts for almost all the COVID-19 cases in the U.S.,鈥� said David Wohl, MD, professor of medicine in the division of infectious diseases.
鈥淲e continue to need effective ways to treat patients to help them avoid severe illness and death. Monoclonals are one tool we have. That said, according to everything we鈥檝e learned since the beginning of the pandemic, the best tools we have to prevent hospitalization and death are vaccines and masking in public indoor places,鈥� he added.